Join KBI Biopharma, Inc. Senior Director of Business Development (Asia Region), Toshihiro (Toshi) Ogawa, at CPhI Japan in April 2022.
Japan’s pharma industry is the 2nd largest in Asia and the 3rd largest worldwide following the US and China. Growth isn’t expected to slow down anytime soon as the booming pharma market in Japan is expected to grow annually. Gathering 300 exhibitors and 16,000 pharma professionals from around the world, CPhI Japan is the ideal platform to meet the biggest pharma companies to tap into this attractive market and source the latest technologies and innovative products!
Visit the conference website >>